Stem Cell Researchers Win Big in EU Court Case

Biotech companies can patent stem cell-producing eggs as long as they cannot be genetically manipulated into becoming a human embryo, the European Court of Justice ruled Thursday. International Stem Cell Corp. applied to the U.K. patent office to protect its technology that produces nonembryonic stem cells from chemically or electronically activated eggs.

http://ift.tt/1w3Aqqb